These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synthesis of some 2,3-disubstituted quinazolones as possible anticonvulsants. Misra VS; Pandey RN; Dua PR Pol J Pharmacol Pharm; 1978; 30(4):573-7. PubMed ID: 740559 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticonvulsant activity of aromatic tetramethylcyclopropanecarboxamide derivatives. Shimshoni JA; Bialer M; Yagen B Bioorg Med Chem; 2008 Jun; 16(11):6297-305. PubMed ID: 18472270 [TBL] [Abstract][Full Text] [Related]
7. Effect of celecoxib on anticonvulsant activity of carbamazepine against maximal electroshock-induced convulsions in mice. Tayal V; Kalra BS; Chawla S Methods Find Exp Clin Pharmacol; 2008 Dec; 30(10):727-30. PubMed ID: 19271020 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of new N-substituted-N'-(3,5-di/1,3,5-trimethylpyrazole-4-yl)thiourea/urea derivatives. Kaymakçioğlu BK; Rollas S; Körceğez E; Aricioğlu F Eur J Pharm Sci; 2005 Sep; 26(1):97-103. PubMed ID: 15990284 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary anticonvulsant activity evaluation of new 2-thioxo-4,5-imidazolidinedione derivatives. Ulusoy N; Ozkirimli S; Gürsu E Boll Chim Farm; 1999 Nov; 138(10):516-20. PubMed ID: 10765468 [TBL] [Abstract][Full Text] [Related]
10. [Development of new antiepileptics. V. Pharmacological activity of some derivatives of sulfanilamide (author's transl)]. Ganz AJ; Waser PG; Pfirrmann RW Arzneimittelforschung; 1978; 28(8):1331-4. PubMed ID: 582398 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticonvulsant activities of 4-N-substituted arylsemicarbazones. Pandeya SN; Kohli S; Siddique N; Stables JP Pol J Pharmacol; 2003; 55(4):565-71. PubMed ID: 14581715 [TBL] [Abstract][Full Text] [Related]
12. [Durene derivates. IV. N-((2,3,5,6-tetramethylbenzoyl)alkyl)imidazoles and N-((beta-(2,3,5,6-tetramethylphenyl)-beta-hydroxy)ethyl)imidazoles with anticonvulsant activity]. Leonardi A; Motta G; Subissi A; Nardi D Farmaco Sci; 1981 Aug; 36(8):711-20. PubMed ID: 7274447 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticonvulsant activity of 1,3-dihydro-5-phenyl-2H-pyrido[3,2-e]-1,4-diazepin-2-ones. Fiakpui CY; Knaus EE Drug Des Discov; 1993; 10(3):173-81. PubMed ID: 8268390 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 2,5-disubstituted 1,3,4-thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies. Rajak H; Deshmukh R; Aggarwal N; Kashaw S; Kharya MD; Mishra P Arch Pharm (Weinheim); 2009 Aug; 342(8):453-61. PubMed ID: 19565600 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticonvulsant activity of N-(2-hydroxyethyl) cinnamamide derivatives. Guan LP; Wei CX; Deng XQ; Sui X; Piao HR; Quan ZS Eur J Med Chem; 2009 Sep; 44(9):3654-7. PubMed ID: 19272675 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of some 2-substituted derivatives of xanthone for anticonvulsant properties. Marona H Pharmazie; 1998 Jun; 53(6):405-9. PubMed ID: 9675771 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins. Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358 [TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant activity of p-chlorophenyl substituted arylsemicarbazones--the role of primary terminal amino group. Pandeya SN; Mishra V; Ponnilavarasan I; Stables JP Pol J Pharmacol; 2000; 52(4):283-90. PubMed ID: 11345484 [TBL] [Abstract][Full Text] [Related]
19. Search for newer substituted phenoxyacetylethyleneimines as possible CNS, MAO and anticonvulsant agents. Shukla JS; Ahmad I Pharmazie; 1981 May; 36(5):327-8. PubMed ID: 7267680 [TBL] [Abstract][Full Text] [Related]
20. Preliminary evaluation of anticonvulsant activity and neurotoxicity of some 1,4-substituted piperazine derivatives. Marona H; Gunia A; Słoczyńska K; Rapacz A; Filipek B; Cegła M; Opoka W Acta Pol Pharm; 2009; 66(5):571-8. PubMed ID: 19894654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]